Release Date: 28/10/10 08:23 Summary: September 2010 Quarterly Activities and Cashflow Reports Price Sensitive: Yes Download Document 589.89KB Download
NEU Neuren Pharmaceuticals dips after pediatric Angelman Syndrome Phase 2 trial results fail to impress
Week 32 Wrap: AI is clearly overhyped – but did we see ‘bubble’ burst already? Plus RBA decision; Japan’s wild week & Google ruling